key: cord-0885334-4c7ug40v
authors: Roe, Kevin
title: A role for T‐cell exhaustion in Long COVID‐19 and severe outcomes for several categories of COVID‐19 patients
date: 2021-07-19
journal: J Neurosci Res
DOI: 10.1002/jnr.24917
sha: 5854bdfe934ad98868437ffbeb8111a5686511ff
doc_id: 885334
cord_uid: 4c7ug40v

Unusual mortality rate differences and symptoms have been experienced by COVID‐19 patients, and the postinfection symptoms called Long COVID‐19 have also been widely experienced. A substantial percentage of COVID‐19‐infected individuals in specific health categories have been virtually asymptomatic, several other individuals in the same health categories have exhibited several unusual symptoms, and yet other individuals in the same health categories have fatal outcomes. It is now hypothesized that these differences in mortality rates and symptoms could be caused by a SARS‐CoV‐2 virus infection acting together with one or more latent pathogen infections in certain patients, through mutually beneficial induced immune cell dysfunctions, including T‐cell exhaustion. A latent pathogen infection likely to be involved is the protozoan parasite Toxoplasma gondii, which infects approximately one third of the global human population. Furthermore, certain infections and cancers that cause T‐cell exhaustion can also explain the more severe outcomes of other COVID‐19 patients having several disease and cancer comorbidities.

Unusual mortality rate differences and symptoms have been observed in COVID-19 infections and in individuals showing the postinfection symptoms known as Long COVID-19 (Carvalho-Schneider et al., 2021; Kozloff et al., 2020; Mendelson et al., 2020; Nemani et al., 2021; Yelin et al., 2020; H. Y. Zheng et al., 2020; . A substantial percentage of COVID-19-infected individuals in various health categories have been virtually asymptomatic, while other individuals in the same health categories have exhibited several unusual symptoms, and still other patients in the same health categories have fatal outcomes (Carvalho-Schneider et al., 2021; Kozloff et al., 2020; Mendelson et al., 2020; Nemani et al., 2021; Yelin et al., 2020; H. Y. Zheng et al., 2020; .

It is hypothesized that these mortality rate differences and symptoms result from a SARS-CoV-2 virus infection acting together with one or more latent pathogen infections in certain patients, through mutually beneficial induced immune cell dysfunctions, such as T-cell exhaustion (Król-Turmińska & Olender, 2017; Varikuti et al., 2018; Xiao et al., 2018; H. Y. Zheng et al., 2020; .

The definition and causes of T-cell exhaustion and the factors determining the prevalence and severity of T-cell exhaustion will be discussed in detail later. One latent pathogen infection that after the passage of time could create T-cell exhaustion is the pervasive protozoan parasite Toxoplasma gondii (Król-Turmińska & Olender, 2017; Varikuti et al., 2018; Xiao et al., 2018) .

T. gondii and other protozoan parasites have achieved intracellular infections in over a billion people (Król-Turmińska & Olender, 2017; Varikuti et al., 2018; Xiao et al., 2018) . T. gondii protozoan parasites typically infect people after food or water ingestion (Król-Turmińska & Olender, 2017) . T. gondii experiences three life stages: tachyzoites during active infections, bradyzoite tissue cysts during latent infections, and sporozoites to infect new hosts from contaminated food or water (Xiao et al., 2018) . Besides T. gondii infections by congenital transmission from mother to fetus, or sporadic-infected organ or tissue transplants, a new host is acquired by ingestion of sporozoites that release activated protozoa to breach the gastrointestinal epithelium, particularly in the small intestine, and enter the host's circulatory system (Xiao et al., 2018) .

T. gondii and other protozoan parasites can create latent infections of the brain and central nervous system (CNS), through tissue cysts in hosts and cause immune system dysfunctions (Xiao et al., 2018) . T. gondii has documented links to several neuropathologies, especially recent onset psychiatric illnesses in some individuals, including schizophrenia, bipolar disorders, obsessive-compulsive disorders, autism, and general anxiety disorders (Xiao et al., 2018) .

T. gondii bradyzoites have been observed in muscles, brain neurons, and the CNS including eye retinas (Xiao et al., 2018) . Individuals having T. gondii infections exhibit brain neuroinflammation, activated microglia and astrocytes in the brain, and complement factor C1q, which can ultimately initiate the classical complement pathway (Xiao et al., 2018) . In addition, T. gondii cysts in the brain can induce major disruptions in the levels of the metabolite kynurenine and neurotransmitters including glutamate, gamma-aminobutyric acid, and dopamine (Xiao et al., 2018) . These neurotransmitter disruptions could also explain some cases of schizophrenia (Xiao et al., 2018) . Long duration latent T. gondii infections can also result in CD8 T-cell exhaustion, which is capable of ultimately inducing T. gondii reactivations and localized tissue inflammations (Xiao et al., 2018) . It is interesting that T-cell exhaustion, such as CD8 T-cell exhaustion, and a weaker antiviral response have also been documented in COVID-19 patients who have more severe infections and outcomes (H. Y. .

It has been recently reported that 41 patients, with ages ranging from 38 to 97 years, who died from COVID-19, had brain autopsies in 2020 at the Columbia University Irving Medical Center (Thakur et al., 2021) . The patients tested before death showed elevated inflammatory cytokines, including elevated interleukin-6 (IL-6) in 26 (96%) of the 27 patients tested (Thakur et al., 2021) . The neuropathological examination of 20 and up to 30 areas from each brain found microglial activation in 34 of the 41 brains (81%) (Thakur et al., 2021) . Microglial clusters (microglial nodules) were found in 26 of the brains (63%), being most prevalent in the brainstem, and neurons were found in some of the microglial nodules, which were interpreted as neuronophagia (Thakur et al., 2021) . However, viral RNA and viral proteins were not significantly detected in the brain cells or the microglial nodules, while acute and subacute hypoxic damage was reported for every brain; thus the formation of the microglial nodules was attributed to hypoxia, instead of the RNA virus SARS-CoV-2 (Thakur et al., 2021) .

It is well documented that brain hypoxia disrupts the bloodbrain barrier (BBB), causing leakage of pro-inflammatory plasma proteins, including immunoglobulins, fibrinogen, and complement (Lana et al., 2020) . It is also well documented that microglial activation and perivascular microglial clusters can be caused by fibrin deposition from perivascular leakage of plasma protein fibrinogen into areas of BBB disruption (Devalos et al., 2012) . In addition, the formation of apoptotic neuron-astrocyte-microglia triads and extensive damage to the myelin sheath (demyelination) from oxidative stress and inflammatory stress has been well documented for brain hypoxia/ ischemia (Lana et al., 2020) . But while neurons were found in some microglial nodules, no apoptotic neuron-astrocyte-microglia triads were reported, and there was no evidence of any demyelination seen in any of the brains autopsied (Thakur et al., 2021) . If there was brain hypoxia, it was apparently of such short duration that not even demyelination from the death of the hypoxia sensitive oligodendrocytes could occur (Lana et al., 2020; Marinelli et al., 2018) .

Therefore, brain hypoxia may not be the main explanation for the microglial nodules. However, there is another well-documented explanation for the microglial nodules that were observed during these brain autopsies.

Unusual mortality rate differences and symptoms are seen in many COVID-19 patients, and the postinfection symptoms called Long COVID-19 are also widespread. These mortality rate differences and symptoms could be caused 

Horses" for intracellular tachyzoite replication and the spread of these active protozoan parasites throughout the brains of infected hosts (Dellacasa-Lindberg et al., 2011) . Infected microglia once activated have demonstrated an ability to transmigrate through astrocytes, which are part of the brain parenchyma and BBB (Dellacasa-Lindberg et al., 2011) . Rapid transfers of these pathogens from infected glial cells to effector T-cells have also been demonstrated (Dellacasa-Lindberg et al., 2011) . Microglial nodules in the brain and CNS have also been widely observed in AIDS patients, where the microglial nodules were caused by T. gondii infections, cytomegalovirus infections, or HIV itself (Dellacasa-Lindberg et al., 2011; Nebuloni et al., 2000; Zhang et al., 2014) . Activated microglia from reactivated T. gondii have also been observed to cause neuronal apoptosis, which could precede neuronophagia (Gottlieb et al., 2020) . T. gondii-activated microglia also lead to elevated levels of the inflammatory cytokines interleukin-1β (IL-1β), IL-6, and tumor necrosis factorα (TNFα) (Zhang et al., 2014) .

In view of the preceding T. gondii symptoms, it is interesting that microglial activation was also found in 81% of the brains of COVID-19 fatalities, and microglial nodules were found in 63% of the brains of COVID-19 fatalities (Thakur et al., 2021) . But while neurons were found in some microglial nodules, no apoptotic neuron-astrocytemicroglia triads were reported, and there was no demyelination found in any of the brains autopsied (Thakur et al., 2021) . But one of the main consequences of brain hypoxia, BBB breakdown, and oxidative and inflammatory stress is axonal demyelination of the neurons (Lana et al., 2020) . If there was brain hypoxia, it apparently had such short duration that not even demyelination occurred. Therefore, T. gondii infections may be an explanation for the microglial activation and microglial nodules observed in the brain autopsies.

Furthermore, in another study a strong link between schizophrenia and a higher mortality rate from SARS-CoV-2 has been observed, with a mortality odds ratio (OR) of 2.67 above normal patients, after adjustment of the OR for age, sex, race, and extra risk factors (Nemani et al., 2021) . The extra schizophrenia risk factors are smoking, cardiovascular disease, diabetes, chronic respiratory disease, antipsychotic medication effects, etc. (Kozloff et al., 2020) . Hamer et al., 2020; Harrison et al., 2020) . There is an explanation provided later in the section that discusses the factors that will increase the severity of T-cell exhaustion that can explain why the mortality rate continues to increase with age without reaching a plateau. In addition, an increased mortality rate for males compared to females (adjusted OR for males of at least 1.6 relative to females), and an increased mortality rate for patients having body mass indexes of 30 to 35 (adjusted OR of 1.2 to 1.37) have also been reported (Gottlieb et al., 2020; Hamer et al., 2020; Harrison et al., 2020; Roe, 2021) .

Interesting matches are noticeable between the OR of mortality of these individual categories and each category's corresponding OR of T. gondii infections (Gottlieb et al., 2020; Hamer et al., 2020; Harrison et al., 2020; Roe, 2021; Wilking et al., 2016) . In 6,663

German adults, the detection of serum IgG antibodies to T. gondii progressively increased from 20% for ages 18-29 to 77% for ages 70-79 (Wilking et al., 2016) . Males had increased T. gondii rates of infection compared to females (OR of 1.8), and there were increased 

Latent infections, such as T. gondii infections, may in some cases explain the increased mortality rates for some COVID-19 patient categories. Furthermore, latent infections in some cases may be the reason why some patients suffer severe COVID-19 symptoms, and may also be the reason why a large number of individuals experience "Long COVID-19" (Carvalho-Schneider et al., 2021; Mendelson et al., 2020; Yelin et al., 2020) . A considerable percentage of post-COVID-19 individuals exhibit numerous and long duration neurological and psychological symptoms, such as: dyspnea (labored breathing), anosmia (impaired sense of smell), dysgeusia (impaired sense of taste), fatigue, chest pain, joint pain, hair loss, memory and attention deficits, anxiety, depression, sleep disorders, tinnitus (ringing in the ear), vertigo (dizziness), otalgia (earache), speech and swallowing deficits (Almufarrij & Munro, 2021; Amenta et al., 2020; Carvalho-Schneider et al., 2021; Mendelson et al., 2020; Yelin et al., 2020) .

It is interesting that the unusual symptoms of Long COVID-19 match the symptoms caused by a partially or fully reactivated T. gondii toxoplasmosis (Bordoni et al., 2021; Costa, 2018; Halonen & Weiss, 2013; Sonne & Lopez-Ojeda, 2021; Vidal, 2019 

Questions may be raised concerning the ability of the SARS-CoV-2 virus to infect the brain and CNS to work together with latent infections in the brain and CNS. It is now recognized that coronaviruses, including the SARS-CoV-2 virus, can infect the brain and CNS by either a blood circulation pathway through the BBB, and/or by a neuronal pathway through sensory nerves (e.g., the olfactory nerve) or through motor nerve endings (Wu et al., 2020 ). An increased BBB permeability has been shown, due to elevated levels of interleukin-1β and TNFα in COVID-19 patients having severe symptoms, and these elevated inflammatory cytokines can be released from injured lung epithelial tissues and/or blood vessel endothelial tissues (McFarland et al., 2021) . Increased BBB permeability will also assist brain entry by the SARS-CoV-2 virus (Kumari et al., 2021; McFarland et al., 2021; Wherry & Kurachi, 2015) .

To summarize at this point, a latent protozoan parasite infection in the brain and CNS, such as T. gondii, can over time create T-cell exhaustion that interacts with SARS-CoV-2 virus in the brain and CNS to create long-term neurological and psychological symptoms, and this interaction may explain many of the unusual and diverse symptoms of COVID-19 or Long COVID-19 (Carvalho-Schneider et al., 2021; Mendelson et al., 2020; Yelin et al., 2020 ).

It should be noted that the mutually beneficial T-cell exhaustion (Cader et al., 2018; Dyck & Mills, 2017; Kong et al., 2016; Kurachi, 2019) . And the severity of T-cell exhaustion is determined by both the abundance (titer) of the antigens, such as from increased pathogen numbers (e.g., increased pathogen and antigen levels from primary or secondary viremia), and by the time duration of the antigen stimulation (Cader et al., 2018; Dyck & Mills, 2017; Kong et al., 2016; Kurachi, 2019) . This is significant, because this also implies that long duration cancers and latent pathogen infections in combination with sufficient inflammation and antigen abundance can cause more severe T-cell exhaustion. Therefore, older individuals will generally also be more likely to have more severe T-cell exhaustion with all its consequences for higher mortality. This would be yet another logical explanation for the increasing mortality rate of older individuals infected by SARS-CoV-2, in addition to the increasing number of comorbidities and general weakening of the immune system with increasing age.

T-cell exhaustion is associated with the loss of T-cell effector functions, reduced proliferative and cytotoxic capacities and impaired production of interleukin-2 and pro-inflammatory cytokines, and increased expression of inhibitory receptors, including the programmed cell death protein 1 (PD-1) receptor, cytotoxic T lympho- These are not precise symptoms and may be reported interchangeably. Kurachi, 2019 (Cader et al., 2018; Das et al., 2017; Dyck & Mills, 2017; Gottlieb et al., 2020; Harrison et al., 2020; Kong et al., 2016; Makary, 2020; Saleh et al., 2020) . The worse outcomes for these COVID-19 cancer patients can be explained by a bidirectional synergy between the SARS-CoV-2 virus and certain cancers through T-cell exhaustion and other immune cell dysfunctions.

One fundamental question that should be addressed is whether 

It is important to note that there are actually at least 11 different genetic types (haplogroups) of T. gondii, with major differences in their growth, migration, and transmission characteristics, and very substantial differences exceeding five orders of magnitude in terms of their effects on the immune system and their virulence (Halonen & Weiss, 2013) . It should also be noted that there is a very significant geographical influence on the distribution of the specific T.

gondii haplogroups (Halonen & Weiss, 2013) . For example, the T. Note: Several intracellular pathogens, latent or active, can induce T-cell exhaustion, especially CD8 T-cell exhaustion, that will benefit themselves or a second intracellular pathogen, such as SARS-CoV-2.

T. gondii can also benefit from SARS-CoV-2 to create the symptoms of Long COVID-19.

Abbreviations: BMI, body mass index; OR, odds ratio. gondii haplogroups (predominantly Type II) of North America are the same as in Europe, but they are much less virulent compared to the very virulent T. gondii haplogroups (e.g., Type I) of South America (Halonen & Weiss, 2013) . Therefore, the specific haplogroup of T.

gondii being studied in a specific country or continent should be identified and specified because of their very substantial immunological differences. Such differences could also explain some differences in COVID-19 severity in various populations.

There are several drug treatments for T. gondii infections, such as sulfamethoxazole and trimethoprim, and it has been demonstrated that early initiation of such drug treatments for T. gondii infections can greatly reduce later induced T-cell dysfunctions, including CD8

T-cell exhaustion, in the late stage of chronic infection (Bhadra et al., 2011) . CD8 T-cells normally produce interferonγ and cytotoxic granzyme B to control toxoplasmosis and block reactivation of T.

gondii cysts, but these are also generally used to suppress viral infections (Bhadra et al., 2011) . Therefore, if T-cell exhaustion and other dysfunctions can be blocked by early drug treatments for protozoan parasite infections, then effective CD8 T-cell responses to later viral infections, including SARS-CoV-2, could essentially be maintained (Bhadra et al., 2011) . These drug treatments, if timely, could essentially mitigate the increased risk of mortality of COVID-19 patients having protozoan parasite infections. 

One way to directly prove the connection between Long COVID-19

and toxoplasmosis is to measure the IgG antibodies to T. gondii in the blood of people suffering from Long COVID-19, and compare their IgG antibody measurements to people who did not suffer any Long COVID-19 after their COVID-19 infection. Other options include taking computed tomography scans of the brains or extracting brain tissue samples from both groups of people during postmortem autopsies to compare the prevalence of lesions from T. gondii infections in patients to cases of Long COVID-19 or fatal COVID-19. It would also be worthwhile to determine the specific haplogroup of T. gondii being studied, since these haplogroups have enormous differences in their characteristics and consequences. More importantly, the matches in corresponding patient categories between the OR of COVID-19 mortality and T. gondii infection suggest T. gondii in certain cases, especially in cases without early protozoan parasite drug treatments, can induce immune dysfunctions which cause more severe outcomes for these COVID-19 patient categories. In addition, some cancers and pathogens which also

induce T-cell exhaustion can explain the more severe outcomes of COVID-19 patients experiencing certain cancer or disease comorbidities. Furthermore, latent pathogen infections that are partially or fully reactivated for any reason could explain why certain post-COVID-19 individuals experience the long duration symptoms of Long COVID-19.

The author has no potential conflict of interest.

The author was the sole contributor in all aspects.

The author confirms that the ethical policies of the journal, as noted on the journal's author guidelines page, have been adhered to. No ethical approval was required as this is an article with no original research data.

The peer review history for this article is available at https://publo ns.com/publo n/10.1002/jnr.24917.

https://orcid.org/0000-0002-4843-9835

Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections

One year on: An updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms

Postacute COVID-19: An overview and approach to classification

Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade

Neuroanatomy, cranial nerve 8 (Vestibulocochlear). StatPearls

Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory Tcell-rich and exhausted T-effector microenvironment

Follow-up of adults with non-critical COVID-19 two months after symptoms' onset

Neural control of swallowing

Tim-3 and its role in regulating anti-tumor immunity

Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation

Atypical multifocal choroiditis in a COVID-19 positive patient

Migratory activation of primary cortical microglia upon infection with Toxoplasma gondii

A possible link between the Epstein-Barr virus infection and autoimmune thyroid disorders

Immune checkpoints and their inhibition in cancer and infectious diseases

Myeloid-derived suppressor cells: The dark knight or the joker in viral infections?

Clinical course and factors associated with hospitalization and critical illness among COVID-19 patients in Chicago

Overweight, obesity, and risk of hospitalization for COVID-19: A communitybased cohort study of adults in the United Kingdom

Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis

T-cell immunoglobulin and ITIM domain (TIGIT) associates with CD8+ Tcell exhaustion and poor clinical outcome in AML

The COVID-19 global pandemic: Implications for people with schizophrenia and related disorders

Human infections caused by free-living amoebae

Neuroinvasion and encephalitis following intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice

CD8+ T-cell exhaustion

An overview on the differential interplay among neurons-astrocytes-microglia in CA1 and CA3 hippocampus in hypoxia/ischemia

Risk factors for COVID-19 mortality among privately insured patients, a claims data analysis, a FAIR health white paper

Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: Implications for COVID-19 and pain

Infection and immune control of human oncogenic γ-herpesviruses in humanized mice

Targeting channels and transporters in protozoan parasite infections

Long-COVID: An evolving problem with an extensive impact

Etiology of microglial nodules in brains of patients with acquired immunodeficiency syndrome

Association of psychiatric disorders with mortality among patients with COVID-19

Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T-cell immunity

T-cell metabolism in chronic viral infection

The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections

Expression of immune checkpoints and T-cell exhaustion markers in early and advanced stages of colorectal cancer

Cytomegalovirus: A troll in the ICU? overview of the literature and perspectives for the future

Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion

Neuroanatomy, cranial nerve. StatPearls

COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital

Host-directed drug therapies for neglected tropical diseases caused by protozoan parasites

HIV-related cerebral toxoplasmosis revisited: Current concepts and controversies of an old disease

Redefining chronic viral infection

Molecular and cellular insights into Tcell exhaustion

Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: A representative, cross-sectional, serological study

Emergence of distinct multiarmed immunoregulatory antigen-presenting cells during persistent viral infection

Nervous system involvement after infection with COVID-19 and other coronaviruses

Toxoplasma gondii: Biological parameters of the connection to schizophrenia

Long COVID-19-it's not over until?

Activated microglia contribute to neuronal apoptosis in Toxoplasmic encephalitis

Elevated exhaustion levels and reduced functional diversity of T-cells in peripheral blood may predict severe progression in COVID-19 patients

Functional exhaustion of antiviral lymphocytes in COVID-19 patients